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Abstract
Background: Despite the importance of 5-HT1A as a major target for the action of several anxiolytics/antidepressant
drugs, little is known about its regulation in central serotonin (5-hydroxytryptamine, 5-HT) neurons.
Results: We report that expression of 5-HT1A and the transcription factor Pet1 was impaired in the rostral raphe
nuclei of mice lacking tryptophan hydroxylase 2 (Tph2) after birth. The downregulation of Pet1 was recapitulated in
5-Ht1a-/- mice. Using an explant culture system, we show that reduction of Pet1 and 5-HT1A was rescued in Tph2-/-
brainstem by exogenous 5-HT. In contrast, 5-HT failed to rescue reduced expression of Pet1 in 5-Ht1a-/- brainstem
explant culture.
Conclusions: These results suggest a causal relationship between 5-HT1A and Pet1, and reveal a potential
mechanism by which 5-HT1A-Pet1 autoregulatory loop is maintained by 5-HT in a spatiotemporal-specific manner
during postnatal development. Our results are relevant to understanding the pathophysiology of certain
psychiatric and developmental disorders.
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Background
Central serotonin (5-hydroxytryptamine, 5-HT) neurons
are composed of a cluster of nine groups (B1-9) located
in the raphe nuclei and in the reticular formation of the
brainstem: The caudal serotoninergic neurons (B1-3) pro-
ject to the spinal cord and modulate sensory transmission,
whereas the rostral serotonergic neurons (B4-9) project
to the brain and modulate a wide spectrum of behaviors
[1,2]. The development of the central 5-HT system in
rodents is subjected to a highly coordinated regulation of
both intrinsic and extrinsic factors [3,4]. After the estab-
lishment of the central serotonergic system, a matured
neurotransmitter phenotype manifested by the persistent
expression of a myriad of transcription factors, enzymes,
and synaptic proteins is maintained through mechanisms
that are yet to be elucidated. Conceivably, an impaired
maintenance of 5-HT neuronal phenotype may contribute
to abnormal physiologic function and the etiology of psy-
chiatric disorders such as depression, anxiety and schizo-
phrenia [5-9].
Molecular and genetic studies of mouse mutants have
identified several transcription factors important for the
specification and acquisition of the central 5-HT neuronal
phenotype [10-12]. In postmitotic serotoninergic neurons,
Pet1, Gata3 and Lmx1b have been shown to regulate dif-
ferentiation and survival of central 5-HT neurons because
their deletion invariably results in a loss of 5-HT and the
failure of 5-HT neurons to survive, either completely or
partially [13-15]. On the other hand, the persistent expres-
sion of these transcription factors in serotonergic neurons
during postnatal stages raises the possibility that they may
be necessary for maintaining the 5-HT neurotransmitter
phenotype during postnatal stage.
Serotonin exerts its function through a complex 5-HT
receptor system comprised of at least 14 receptors, in-
cluding several autoreceptors [16-18]. Many of 5-HT re-
ceptors show distinct spatiotemporal expression patterns
in the brain, and the function of a 5-HT receptor may
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vary depending on where and when it is expressed. For
example, 5-HT1A mediates anxiety behavior through
its expression in the cortex during the early postnatal
life rather than in adult stage [19,20]. A recent study has
shown that altered expression of 5-HT1A autoreceptor
without changing postsynaptic 5-HT1A has major im-
pacts in physiological processes and animal behaviors
[21]. Although overwhelming studies have been focused
on 5-HT heteroreceptors, the role of 5-HT and its auto-
receptors in the development and maintenance of cen-
tral 5-HT neurons is poorly understood. We previously
generated Lmx1bf/f/p conditional knockout mice in which
Lmx1b is specifically deleted in cells expressing tran-
scription factor Pet1, a transcription factor exclusively
expressed in central 5-HT neurons [22,23]. LMX1B is a
LIM homoeodomain-containing transcription factor, which
is required for the development of all central serotonergic
neurons during embryogenesis [13,24]. Because loss of
Lmx1b results in the loss of 5-HT as well as all central
5-HT neurons in Lmx1bf/f/p mice at later stage [22], it is
impossible to examine the requirement for 5-HT in the de-
velopment of 5-HT neurons. To circumvent this problem,
we have generated and analyzed mice lacking tryptophan
hydroxylase 2 (TPH2), an enzyme essential for synthesizing
5-HT in the brain [25]. Although 5-HT appears to be dis-
pensable for the development of central 5-HT neurons
during embryogenesis, we found that it is important for
maintaining the differentiated 5-HT neurotransmitter
phenotype after birth.
Results
Normal generation and migration of presumptive central
serotonergic neurons in Tph2-/- mice
To generate Tph2-/- mice, two loxP sites were inserted to
flank the exon 5 that encodes eukaryotic tryptophan hy-
droxylase domain essential for 5-HT synthesis (Figure 1A).
The deletion of the Tph2 exon 5 would generate a trun-
cated non-functional protein. After electroporation with
the targeting vector, several targeted ES cell clones were
identified, and the germline transmission was obtained
(Figure 1B). Actb cre mice were mated with Tph2f/+ mice
to inactivate Tph2 in the germline, and Tph2+/- and
Tph2-/- mice were born at the expected mendelian ratio.
Tph2-/- mice showed decreased body weight and size rela-
tive to wild-type littermates beginning at postnatal day 6
(P6) and by 6 weeks of age all mutant mice showed
normal body weight (Figure 1C). The body weight in-
crease profile of our mutant mice is consistent with a re-
cent study [26], but different from another report [27].
All Tph2-/- mice in C57BL/6/129 background survived to
the adulthood. Immunohistochemical analysis revealed no
presence of 5-HT in the raphe nuclei and spinal cord of
Tph2-/- mice, whereas expression of 5-HT in the periph-
eral tissues was normal (Figure 1D). The absence of Tph2
expression in Tph2-/- mice was confirmed (Figure 1E).
These data demonstrated that Tph2 is the sole enzyme re-
sponsible for 5-HT synthesis in the brain, consistent with
other reports [28-30]. To determine whether a loss of 5-
HT may impair 5-HT neuronal differentiation, several
molecular markers were examined in wild-type and
Tph2-/- mice. In situ hybridization studies of serotonin
transporter (Sert) [31] revealed neither the expression
pattern nor the number of Sert+ cells in the rostral
raphe nuclei in Tph2-/- mice was affected by the absence
of 5-HT (Figure 1E). Expression of the aromatic L-amino
acid decarboxylase gene (AADC) and vesicular monoamine
transporter (VMAT2) was also comparable between wild-
type and Tph2-/- hindbrain (Figure 1E). These results indi-
cated the normal presence of presumptive 5-HT neurons
in Tph2-/- mice, and 5-HT is required neither for the mi-
gration nor for the survival of central 5-HT neurons, in
line with recent findings that showed normal expression of
differentiation markers in Tph2-/- mice [27].
Downregulation of Pet1 and Gata3 expression in the
rostral raphe nulcei of Tph2-/- mice
To further analyze the differentiation phenotype of pre-
sumptive 5-HT neurons, we examined the expression of
transcription factors in the raphe nuclei of adult Tph2-/-
mice during embryonic and early postnatal development.
At E17.5, Pet1 and Gata3 expression was indistinguishable
between wild-type and Tph2-/- hindbrain (Figures 2A, B,
E17.5). Beginning at P0 the expression of Pet1 and Gata3
was significantly reduced in the rostral raphe nuclei of
Tph2-/- mice compared with wild-type mice (Figures 2A,
B, P0), which persisted at adult stage (Figure 2A, B, 8-
week). The expression of Pet1 and Gata3 remains un-
changed in the caudal raphe nuclei (B1-3) of Tph2-/- mice
(Figure 2A, B). The expression pattern of LMX1B and the
number of LMX1B+ cells were similar between wild-type
and Tph2-/- mice (Figure 2C).
Reduced expression of Pet1 but not Gata3 in 5-Ht1a-/- mice
The downregulation of Pet1 and Gata3 in Tph2-/- mice
suggests that their normal expression may be maintained
by 5-HT via 5-HT autoreceptors. To examine this possi-
bility, we first compared expression level of three 5-HT
autoreceptors, 5-Ht1a, 5-Ht1b and 5-Ht1d, in the hind-
brain of Tph2+/+ mice and Tph2-/- mice using real-time
RT-PCR (qRT-PCR). 5-Ht1a expression was significantly
reduced in Tph2-/- hindbrain relative to the control,
while the expression of 5-Ht1b and 5-Ht1d was un-
altered (Figure 3A). Immunostaining of 5-HT1A showed
a reduction in the number of 5-HT1A+ cells (~25.7%) in
B7-8 nuclei of Tph2-/- mice compared with wild-type mice
(Figure 3B, C). The expression of 5-HT1A was not affected
in other brain regions of the Tph2-/- mice (Figure 3B).
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Figure 1 Generation and characterization of Tph2-/- mice. (A) Top: Schematic diagram of the genomic locus for the Tph2 gene. Middle: the
gene-targeting construct. Bottom: targeted Tph2 allele. The black box denotes the coding exon. (B) Southern blot analysis of wild-type (Tph2+/+)
and targeted ES clone (Tph2f/+). Predicted size of the genomic fragments was detected. (C) Growing curve of male and female Tph2+/+ and
Tph2-/- mice from P1 to 8-week. (D) Anti-5-HT immunoreactivity in the dorsal raphe (left), spinal cord (middle) and intestine (right) of Tph2+/+ mice
(upper row) and Tph2-/- mice (lower row). (E) Images (left) and quantified data (right) to show in situ hybridization of Tph2, Sert, AADC and VMAT2
in Tph2+/+ and Tph2-/- mice. Error bars represent SEM. n = 5. Scale bars, 100 μm.
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Figure 2 (See legend on next page.)
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These results suggest that 5-HT is involved in the regula-
tion of 5-HT1A expression in a highly specific manner.
We next asked whether the maintenance of Pet1 and
Gata3 expression depends on 5-HT1A by examining their
expression in 5-Ht1a-/- mice [32]. Pet1 was significantly
diminished in 5-Ht1a-/- mice relative to wild-type mice at
P0 (approximately ~29.8% loss of Pet1 in B7-B8 nuclei)
(Figure 4). Interestingly, Gata3 expression was normal in
the raphe nuclei of 5-Ht1a-/- mice (Figure 4), and so were
Tph2, AADC, VMAT2 and LMX1B (Figure 4A). These
findings suggest that 5-HT can regulate Pet1, but not
Gata3, through 5-Ht1a in the rostral raphe nuclei.
(See figure on previous page.)
Figure 2 The expression of Pet1 and Gata3, but not LMX1B was decreased in the dorsal raphe nuclei of Tph2-/- mice. (A and B)
Expression of Pet1 (A) and Gata3 (B) detected by in situ hybridization in the dorsal and caudal raphe nuclei of Tph2+/+ mice and Tph2-/- mice at
embryonic day 17.5 (E17.5), postnatal day 0 (P0) and adult stages. (C) Immunohistochemistry images and quantified data to show LMX1B
expression in the dorsal and caudal raphe nuclei of adult Tph2+/+ mice and Tph2-/- mice. Error bars represent SEM. n = 6. *P < 0.05, versus Tph2+/+,
unpaired t test. Scale bars, 100 μm.
Figure 3 5-HT1A expression was decreased in the dorsal raphe nuclei of Tph2-/- mice. (A) qRT-PCR analysis of 5Ht1a, 5Ht1b and 5Ht1d in
Tph2+/+ and Tph2-/- hindbrain. Tph2 mRNA level in the Tph2-/- hindbrain was used as a negative control. Relative expression was quantified using
18S rRNA as reference gene. (B) Immunostaining of 5-HT1A in the dorsal raphe nucleus, cortex, polymorph layer dentate gyrus (PoDG), inferior
colliculus central nucleus (ICc) and superior colliculus (SC) of Tph2+/+ mice and Tph2-/- mice. (C) Quantification of 5-HT1A+ neurons in B7-8 raphe
nucleus. Error bars represent SEM. n = 6. *P < 0.05, versus Tph2+/+, unpaired t test. Scale bars, 100 μm.
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Exogenous 5-HT rescued the expression of Pet1 and
5-Ht1a in Tph2-/- brainstem
To further test this possibility, we asked whether the
downregulation of Pet1 in Tph2-/- hindbrain would be
rescued by 5-HT in Tph2-/- mice, and if so, whether this
rescue could be blocked by the 5-HT1A antagonist. In-
deed, qRT-PCR analysis of Pet1 expression showed that
the reduced expression of Pet1 was partially rescued in
Tph2-/- hindbrain explants by 5-HT (Figure 5A). Import-
antly, this rescued effect was abolished with the treatment
of WAY-100635, a potent selective 5-HT1A antagonist
[33]. In contrast, in 5-Ht1a-/- hindbrain explants, the ex-
pression level of Pet1 was neither significantly altered by
5-HT nor by a combined treatment of 5-HT and WAY-
100635 (Figure 5A). Together, these results provide
further evidence suggesting that 5-HT regulates Pet1
expression via 5-Ht1a.
We next assessed whether downregulation of 5-Ht1a
expression in Tph2-/- mice could be rescued by 5-HT
using the explant culture. qRT-PCR analysis showed a
significant increase in 5-Ht1a expression in Tph2-/- hind-
brain explants after treatment with 5-HT compared with
the saline treatment (Figure 5B). Our data thus support
the role of 5-HT in regulating 5-Ht1a expression.
Discussion
5-HT has long been postulated as an important signaling
molecule necessary for regulating multiple developmen-
tal processes such as neurogenesis, differentiation, and
survival of central 5-HT neurons [34,35]. Although sev-
eral recent studies have reported the physiological and
developmental consequences resulting from an ablation
of central serotonin by genetic deletion of Tph2 gene
[27-30], definite in vivo evidence for a developmental
role of 5-HT is still lacking. In this study, we found that
mice lacking central 5-HT exhibited normal position
and numbers of presumptive 5-HT neurons in the
raphe nuclei, indicating that 5-HT is dispensable for
their migration and survival. Nonetheless, the early
postnatal expression of Pet1, Gata3 and 5-Ht1a was sig-
nificantly impaired in the mutants. Our studies thus for
the first time uncover an important function of 5-HT in
the maintenance of differentiation program of central 5-
HT neurons.
Figure 4 The expression of Pet1 but not Gata3 was decreased in 5Ht1a-/- mice. (A) In situ hybridization images to show the expression of
Pet1, Gata3, Tph2, AADC and VMAT2 and immunostaining of LMX1B in the dorsal raphe nuclei of 5-Ht1a+/+ mice (upper row) and 5-Ht1a-/- mice
(lower row). (B) Quantification of positive cells for Pet1 and Gata3 in B7-8 raphe nuclei. Error bars represent SEM. n = 6. *P < 0.05, versus 5-Ht1a+/+,
unpaired t test. Scale bar, 100 μm.
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Which receptor mediates the function of 5-HT to
maintain the differentiated 5-HT neuronal phenotype?
Several observations indicate that 5-HT functions via 5-
HT1A to regulates Pet1, which in turn may control an
appropriate expression of 5-HT1A in 5-HT neurons.
First, Pet1 is significantly reduced in the rostral raphe
nuclei of Tph2-/- mice, and 5-Ht1a-/- mice recapitulate
this phenotype. Second, decreased expression of Pet1 in
Tph2-/- mice was rescued by 5-HT treatment, whereas
the same treatment failed to rescue Pet1 reduction in 5-
Ht1a-/- mice. Third, previous studies identified at least
one Pet1 binding site in the regulatory regions of both
human and mouse 5-Ht1a [23,36], suggesting that Pet1
can also act upstream of 5-Ht1a. It will be interesting to
examine whether 5-Ht1a expression is regulated by Pet1
using Pet1 mutant mice. However, addressing this issue
would be complicated by the possibility that Pet1 may
regulate Tph2 (thus 5-HT level) and 5-Ht1a simultan-
eously. Our results are different from several recent
studies which showed that expression of 5-Ht1a autore-
ceptor in dorsal raphe nuclei was slightly increased in
Tph2-/- mice [27] or remained the same [37]. Several
factors may contribute to the discrepancies. First, differ-
ent methods that have been employed (quantitative
autoradiography vs. ISH and qRT-PCR). Second, differ-
ent lines of Tph2 knockout mice may vary due to differ-
ent genetic backgrounds. The postnatal growth profile of
our Tph2-/- mice is reminiscent of the one generated by
another lab [30], with a catch-up in body weight at adult
stage. In contrast, another line of Tph2-/- mice exhibited
lean body weight, even at the adult stage [27]. Finally,
conditional Tph2-/- mice showed low level of 5-HT due
to incomplete deletion of Tph2 [37]. Our Tph2-/- mice
completely lack 5-HT in the brainstem. In light of these
differences, behavioral phenotype of various lines of
Tph2 mutant mice ought to be carefully interpreted,
given that expression of 5-ht1a autoreceptor is very sen-
sitive to the 5-HT level. The normal growth of Tph2-/-
mice affords distinct advantage because exogenous ad-
ministration of 5-HTP could fully restore a behavioral
phenotype [38], thereby attributing the phenotype to
lack of 5-HT instead of developmental changes. Recent
analysis of these mutant mice also shed light on the role
of 5-HT in the reward system [39]. Nevertheless, the
0.0
0.3
0.6
0.9
1.2
*
#
WT Tph2-/- Htr1a-/-
R
el
at
iv
e 
ex
pr
es
si
on
(fo
ld
 c
ha
ng
e)
0.0
0.3
0.6
0.9
1.2
*
Saline
5-HT
5-HT+WAY100635
WT Tph2-/-
R
el
at
iv
e 
ex
pr
es
si
on
(fo
ld
 c
ha
ng
e)
Pet1 5-Ht1a
BA
C
Figure 5 The regulation of Pet1 and 5-Ht1a expression by 5-HT in brainstem explants. (A and B) The hindbrain explants of Tph2-/- mice,
5-Ht1a-/- mice and their littermates wild-type mice were treated with 5-HT either alone or in combination with WAY-100635, and the expression
level of Pet1 (A) and 5-Ht1a (B) was measured using qRT-PCR. Relative expression was quantified using 18S rRNA as reference gene. Error bars
represent SEM. n = 5. *P < 0.05, versus Saline and #P < 0.05, versus 5-HT, one-way ANOVA followed by post hoc analysis. (C) Diagram to show a
5-HT-dependent 5-Ht1a/Pet1 auto regulatory feedback loop.
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present data provide the genetic, molecular and pharma-
cological evidence suggesting that 5-Ht1a and Pet1 may
act in an autoregulatory feedback pathway, whose integ-
rity is dependent on 5-HT (Figure 5C).
One notable finding is that the 5-HT-dependent main-
tenance program exhibits a highly regulated spatiotem-
poral specificity: its requirement is restricted only to
postnatal rostral raphe nuclei. Given that distinct genetic
mechanisms are likely to be recruited to coordinate spa-
tiotemporal development of different subtypes of 5-HT
neurons [40], the observation that the requirement for
5-HT-mediated transcriptional regulation is restricted to
rostral raphe nuclei may underlie the heterogeneity of
central 5-HT neurons. Our results suggest that the main-
tenance of the maturation and differentiation of 5-HT
neurons invoke 5-HT-dependent and -independent mo-
lecular machineries. This heterogeneity is also manifested
at transcriptional level. For example, we show that postna-
tal maintenance of Lmx1b is independent of Pet1 and
Gata3, whereas Gata3 expression is independent of Pet1
in the rostral raphe nuclei. It is surprising that an impaired
expression of Pet1 in postnatal 5-Ht1a-/- mice did not
affect expression of several Pet1 binding site-containing
terminal differentiation genes (e.g. Sert and VMAT2)
which were downregulated in Pet1-/- mice [14]. Perhaps
other transcription factors such as Lmx1b may be re-
quired. Alternatively, a complete rather than a partial
elimination of Pet1 may be necessary to reveal a full
transcriptional requirement in the regulation of down-
stream effectors. The finding that Gata3 is down-
regulated by the absence of 5-HT but not by 5-HT1A
also suggests that several 5-HT autoreceptors coordin-
ate to regulate transcription factor expression.
5-HT1A has emerged as a major target for pharmaco-
logical intervention against a wide spectrum of psychi-
atric diseases [41-43]. In addition to its postsynaptic
action, activation of 5-HT1A on the soma and dendrites
of 5-HT neurons has been shown to inhibit the release
of 5-HT as well as the firing rate of 5-HT neurons [44,45];
Conversely, blockage or desensitization of 5-HT1A in 5-
HT neurons enhances the firing rate of 5-HT neurons
and/or the 5-HT signaling, a mechanism suggested to be
partly underlie the actions of anxiolytic and antidepressant
drugs [46-48]. Importantly, a recent study showed that
about 30% decrease of 5-HT1A in the raphe nuclei in-
creased the firing rate of 5-HT neurons and subsequently
impacted several aspects of animal behaviors including
the responses of animals to antidepressants [21]. Our
studies suggest that a normal 5-HT homeostasis is neces-
sary for a full expression of 5-HT1A in the rostral raphe
nuclei of the brainstem. An altered 5-Ht1a/Pet1 expres-
sion and regulation may impact other 5-HT autoreceptors
and thereby contribute to the development of mood
disorders (e.g. major depressive disorder, aggression and
anxiety) [21,42,46,47,49,50]. In this context, the identifica-
tion of a 5-HT-dependent 5-Ht1a/Pet1 autoregulatory
feedback loop (Figure 5C) required for maintaining appro-
priate 5-HT signaling and homeostasis in postnatal raphe
nuclei is of important clinical implications for designing
target-specific therapeutic intervention of these disorders.
Methods
Animals
5-Ht1a KO mice and Actb-cre mice were genotyped as
previously described [32,51]. Experimental procedures
were conducted in accordance with policies of the Na-
tional Institutes of Health and were approved by the
Animal Studies Committee at Washington University
School of Medicine.
Generation and genotyping of Tph2-/- mice
Tph2 targeting vector was generated by bacterial recom-
bineering approach as previously described [52]. Mouse
genomic 129/SvJ DNA was obtained from Sanger Institute
(UK). The PGK-neomycin-resistance (neo) and thymidine
kinase (TK) cassette was inserted as a positive and nega-
tive drug selection marker. The linearized targeting plas-
mid was electroporated into AB1 ES cells. Correctly
targeted ES cell clones identified by Southern blot analysis
using external probes were injected into C57BL/6 blasto-
cysts to generate chimeric mice. Male chimeras were
mated with wild-type females to produce heterozygous
mice. The primers used for PCR genotyping were 5′-G
CAGCCAGTAGACGTCTCTTAC-3′, 5′-ACCACATTG
ACATACGGGTC-3′ and 5′-TGGGGCCTGCCGATAGT
AACAC-3′ and 420 bp wild-type and 640 bp mutant
bands were produced, respectively.
Immunohistochemistry and in situ hybridization
Immunohistochemical staining and in situ hybridization
were performed as previously described [22]. Briefly,
mice were anesthetized with an overdose of ketamine,
and fixed by intracardiac perfusion with cold PBS
(0.01 M, pH 7.4) followed by 4% paraformaldehyde. The
brain, spinal cord and small intestine were immediately
removed, postfixed in the same fixative overnight at 4°C
and cryoprotected in 30% sucrose solution. Frozen tis-
sue was sectioned at 20 μm thickness using a cryostat.
Free-floating sections were blocked in a solution con-
taining 2% donkey serum and 0.3% Triton X-100 in PBS
for 1 h at room temperature. The sections were incubated
with rabbit anti-5-HT (1:5,000, Immunostar), rabbit anti-5-
HT1A (1:200, Santa Cruz) or rabbit anti-LMX1B (1:1,000,)
antibodies overnight at 4°C followed by Cy3-conjugated
secondary antibodies (Jackson ImmunoResearch). For the
in situ hybridization study, a digoxigenin-labeled cRNA
probe was used as described earlier [22]. Images were
taken using a Nikon Eclipse Ti-U microscope. Images of
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wild-type and knock-out mice were overlaid with the same
plate and box of identical size was centered on a template
image of the comparable rostrocaudal levels using the ven-
tricle and midline nuclei as the reference point. All clearly
visible cells with positive signals within this box were quan-
tified using image J software. Four tissue sections per B nu-
cleus were analyzed in each mouse.
qRT-PCR analysis
qRT-PCR was performed as previously described [53]. The
defined area of the hindbrain was dissected out, and total
RNA was isolated and genomic DNA was removed in ac-
cordance with manufacturer’s instructions (RNeasy plus
mini kit; QIAGEN). Single strand cDNA was synthesized
from RNA samples (2 μg) using SuperScriptII RT-PCR kit
(Life Technologies) in reverse transcription reaction. Gene
expression was determined by real-time PCR (StepOne-
Plus; Applied Biosystems). The primers used are:
Tph2 (NM_173391.3): 5′- GAGCTTGATGCCGACC
AT-3′; 5′- TGGCCACATCCACAAAATAC-3′;
amplicon size: 76 nt.
5-Ht1a (NM_008308.4): 5′-GCCCTGGAAGCAACA
CCTAA-3′; 5′-CTGCAAAAAGCACTGTCCCC -3′;
amplicon size: 115 nt.
5-Ht1b (NM_010482.1): 5′-TCGTTGCCACCCTTC
TTCTG-3′; 5′-CGTGGTCGGTGTTCACAAAG-3′;
amplicon size: 76 nt.
5-Ht1d (NM_008309.4): 5′-GGGTCAATTCATCAAG
AACACA-3′; 5′-GCTTGGAAGCTCTGAGGTGT-3′;
amplicon size: 93 nt.
18S rRNA (NR_003278.3): 5′-AAACGGCTACCACAT
CCAAG -3′; 5′-CCTCCAATGGATCCTCGTTA -3′;
amplicon size: 155 nt.
Real-time PCR was carried out with FastStart Univer-
sal SYBR Green Master (Roche Applied Science).
All samples (0.1 μl) were assayed in duplicates. Thermal
cycling was initiated with denaturation at 95°C for
10 min. After this initial step, 40 cycles of PCR (heating
at 95°C for 10 s and 60°C for 30 s) were performed. Data
were analyzed using Comparative CT Method (StepOne
Software v2.2.2.) and the expression of target mRNA
was normalized to the expression of 18S rRNA.
Hindbrain explant culture
Hindbrain explant culture was performed as described
[54]. Briefly, hindbrains from wild-type and knock-out
mice at P0 were dissected out in cold Leibovitz’s medium
(L15; Invitrogen) with 5% calf serum (Life Technologies).
The explants were cultured for 1 h at 37°C in Neurobasal
medium (Life Technologies) containing 1% calf-serum (Life
Technologies), 0.5% B27 supplement (Life Technologies),
2 mM glutamine (Sigma) and 1% penicillin/streptomycin
(Life Technologies). Subsequently, the medium was re-
placed with serum-free medium and the explants were
treated with 10 μM of 5-HT or 5-HT1A antagonist
WAY-100635 for 6 h. For the use of combination of
WAY-100635 and 5-HT, the explants were pre-treated
with WAY-100635 for 2 h before addition of 5-HT. 5-HT
and WAY-100635 were dissolved in saline and the group
with the saline treatment was used as the vehicle control.
Statistical analysis
All data are presented as mean ± SEM and analyses were
performed using Prism (version 5.03 GraphPad Software,
Inc). Experimental groups were compared by unpaired
two-tailed Student’s t-test or one-way ANOVA of vari-
ance with post hoc analysis. P < 0.05 was considered as
statistically significant.
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